Cochrane Abstracts
Recombinant factor VIIa concentrate versus plasma‐derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Factor VIIa Concentrate Versus Plasma‐derived Concentrates for Treating Acute Bleeding Episodes in People With Haemophilia and Inhibitors." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439862/all/Recombinant_factor_VIIa_concentrate_versus_plasma‐derived_concentrates_for_treating_acute_bleeding_episodes_in_people_with_haemophilia_and_inhibitors.
Recombinant factor VIIa concentrate versus plasma‐derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439862/all/Recombinant_factor_VIIa_concentrate_versus_plasma‐derived_concentrates_for_treating_acute_bleeding_episodes_in_people_with_haemophilia_and_inhibitors. Accessed March 19, 2025.
Recombinant factor VIIa concentrate versus plasma‐derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439862/all/Recombinant_factor_VIIa_concentrate_versus_plasma‐derived_concentrates_for_treating_acute_bleeding_episodes_in_people_with_haemophilia_and_inhibitors
Recombinant Factor VIIa Concentrate Versus Plasma‐derived Concentrates for Treating Acute Bleeding Episodes in People With Haemophilia and Inhibitors [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439862/all/Recombinant_factor_VIIa_concentrate_versus_plasma‐derived_concentrates_for_treating_acute_bleeding_episodes_in_people_with_haemophilia_and_inhibitors.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant factor VIIa concentrate versus plasma‐derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors
ID - 439862
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439862/all/Recombinant_factor_VIIa_concentrate_versus_plasma‐derived_concentrates_for_treating_acute_bleeding_episodes_in_people_with_haemophilia_and_inhibitors
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
